Evidence map›Paper›PMID 26496249›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2016

Deletion of Rac in Mature Osteoclasts Causes Osteopetrosis, an Age-Dependent Change in Osteoclast Number, and a Reduced Number of Osteoblasts In Vivo.

Meiling Zhu, Ben-Hua Sun, Katarzyna Saar, Christine Simpson, Nancy Troiano, Sarah L Dallas, LeAnn M Tiede-Lewis, Erin Nevius, João P Pereira, Robert S Weinstein and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Defective efferocytosis in diabetes: molecular mechanisms and emerging therapeutic strategies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Meiling ZhuDepartment of Internal Medicine, Endocrinology, Yale School of Medicine, New Haven, CT, USA.
Ben-Hua SunDepartment of Internal Medicine, Endocrinology, Yale School of Medicine, New Haven, CT, USA.
Katarzyna SaarDepartment of Internal Medicine, Endocrinology, Yale School of Medicine, New Haven, CT, USA.
Christine SimpsonDepartment of Internal Medicine, Endocrinology, Yale School of Medicine, New Haven, CT, USA.
Nancy TroianoDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA.
Sarah L DallasDepartment of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri, Kansas City, Kansas City, MO, USA.
LeAnn M Tiede-LewisDepartment of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri, Kansas City, Kansas City, MO, USA.
Erin NeviusDepartment of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
João P PereiraDepartment of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
Robert S WeinsteinDepartment of Internal Medicine, University of Arkansas for Medical Sciences and the Central Arkansas Veterans Health Care System, Little Rock, AR, USA.
Steven M TommasiniDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA.
Karl L InsognaDepartment of Internal Medicine, Endocrinology, Yale School of Medicine, New Haven, CT, USA.
Yale University · USUniversity of Missouri–Kansas City · USCentral Arkansas Veterans Healthcare System · US

Funding

TRANSGENIC MOUSE COREP01AG013918 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI O'BRIEN, CHARLES A · 1996 to 2016
$25.7M
Transgenic and Mechanical Loading CoreP01AG039355 · NIA · UNIVERSITY OF MISSOURI KANSAS CITY · PI BONEWALD, LYNDA F · 2012 to 2024
$19.3M
YALE CORE CENTER FOR MUSCULOSKELETAL DISORDERSP30AR046032 · NIAMS · YALE UNIVERSITY · PI HOROWITZ, MARK C · 1999 to 2013
$9.0M
Structure, Composition, & Histology Core - Core BP30AR069620 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARL J JEPSEN · 2016 to 2026
$8.4M
ROLE OF CSF-1 IN OSTEOCLAST FUNCTIONR01DE012459 · NIDCR · YALE UNIVERSITY · PI INSOGNA, KARL LEONARD · 1998 to 2013
$4.4M
COLONY-STIMULATING FACTOR 1--REGULATION AND ROLE IN BONER01DK045228 · NIDDK · YALE UNIVERSITY · PI INSOGNA, KARL LEONARD · 1992 to 2010
$3.3M
Zeiss LSM 710 Confocal Microscopy System for Imaging of Mineralized TissuesS10RR027668 · NCRR · UNIVERSITY OF MISSOURI KANSAS CITY · PI DALLAS, SARAH L · 2011 to 2011
$446k
Role of CSF-1 in Osteoclast FunctionR56DE012459 · NIDCR · YALE UNIVERSITY · PI INSOGNA, KARL LEONARD · 2010 to 2010
$414k
NCRR NIH HHS S10 RR027668NIAMS NIH HHS P30 AR046032NIAMS NIH HHS P30 AR069620NIAMS NIH HHS P30 AR46032NIA NIH HHS P01 AG013918NIA NIH HHS P01 AG039355NIA NIH HHS P01-AG13918NIDCR NIH HHS DE12459NIDCR NIH HHS R01 DE012459NIDCR NIH HHS R56 DE012459NIDDK NIH HHS DK45228NIDDK NIH HHS R01 DK045228
6 · The paper itself

Abstract

Rac1 and Rac2 are thought to have important roles in osteoclasts. Therefore, mice with deletion of both Rac1 and Rac2 in mature osteoclasts (DKO) were generated by crossing Rac1(flox/flox) mice with mice expressing Cre in the cathepsin K locus and then mating these animals with Rac2(-/-) mice. DKO mice had markedly impaired tooth eruption. Bone mineral density (BMD) was increased 21% to 33% in 4- to 6-week-old DKO mice at all sites when measured by dual-energy X-ray absorptiometry (DXA) and serum cross-linked C-telopeptide (CTx) was reduced by 52%. The amount of metaphyseal trabecular bone was markedly increased in DKO mice, but the cortices were very thin. Spinal trabecular bone mass was increased. Histomorphometry revealed significant reductions in both osteoclast and osteoblast number and function in 4- to 6-week-old DKO animals. In 14- to 16-week-old animals, osteoclast number was increased, although bone density was further increased. DKO osteoclasts had severely impaired actin ring formation, an impaired ability to generate acid, and reduced resorptive activity in vitro. In addition, their life span ex vivo was reduced. DKO osteoblasts expressed normal differentiation markers except for the expression of osterix, which was reduced. The DKO osteoblasts mineralized normally in vitro, indicating that the in vivo defect in osteoblast function was not cell autonomous. Confocal imaging demonstrated focal disruption of the osteocytic dendritic network in DKO cortical bone. Despite these changes, DKO animals had a normal response to treatment with once-daily parathyroid hormone (PTH). We conclude that Rac1 and Rac2 have critical roles in skeletal metabolism.

Indexed as

AgingGene DeletionNeuropeptidesOsteoblastsOsteoclastsOsteopetrosisrac1 GTP-Binding Proteinrac GTP-Binding ProteinsAnimalsCell CountHumansMiceMice, KnockoutRAC2 GTP-Binding ProteinNeuropeptidesrac1 GTP-Binding ProteinRac1 protein, mouseRAC2 GTP-Binding Proteinrac GTP-Binding ProteinsOSTEOCLASTSOSTEOCYTESRAC1RAC2

Identifiers

PMID26496249
PMCPMC4826801
OpenAlexW1759014559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.